Sanofi can Shine

30 ก.ย.

Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. It focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospitals, central nervous system, and antihistamines.

Sanofi India Ltd. CMP is 7048.85. The positive aspects of the company are Company with No Debt, Company with Zero Promoter Pledge, Mutual Funds Increased Shareholding over the Past Two Months. The Negative aspects of the company are high Valuation (P.E. = 30.7), Stocks Underperforming their Industry Price Change in the Quarter, Declining profits every quarter for the past 3 quarters and Increasing Trend in Non-Core Income.

Entry can be taken after closing above 7066 Targets in the stock will be 7304 and 7434. The long-term target in the stock will be 7618. Stop loss in the stock should be maintained at Closing below 6679 or 6300 depending on your risk taking ability.

Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.